Weblinks related to COVID-19
Switzerland
- Federal Office of Public Health: Information on the new coronavirus
- Federal council Point de Presse
- Federal government measures
- Swissmedic dedicated website to the COVID-19 pandemic
- Swiss National COVID-19 Science Task Force
International
- WHO global research on corona virus disease
- WHO European situation dashboard
- Johns Hopkins global cases
Guidances (EMA, MHRA, NHS, FDA, NHS, NIH)
- FDA guidance on conducting clinical trials during the pandemic
- EMA advice on clinical trials
- EMA Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials
- EMA MHA Guiance on the management of clinical trials during the COVID-19 pandemic (v3 28.04.2020)
- NHS guidance for sponsors, sites and researchers
- NIH guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
- MHRA Advice for Management of Clinical trials in relation to Coronavirus
- COVID-19 Disruptions of International Clinical Trials: Comparing Guidances Issued by FDA, EMA, MHRA and PMDA, Mark Barnes et al. Ropes&Gray, April 2, 2020
Other guidances (other countries, other documents)
- EFGCP-AWP Covid-19 Repository
- Regulatory – ethical considerations for ongoing trials during Pandemic, ECRIM
- European data protection board: Statement on the processing of personal data in the context of the COVID-19 outbreak
Clinical Research
- Covid-19 Literature Review, ECRIN (list updated every two weeks)
- ICMRA statement on the continuation of clinical trials, Dec, 2020
- International coordination needed to encourage conduct of large, decision-relevant COVID-19 clinical trials. EMA Press Release, May 15, 2020
- MDR Metadata Repository for clinical trial data objects, ECRIN (it includes Covid-19 data)
- Covid-19 Trials Registries ECRIN
- Draft landscape of COVID 19 candidate vaccines, WHO
- Research mapping of candidate COVID-19 therapeutics, displaying studies per country, study design, disease severity in study participants, treatment comparisons, etc., Cochrane, Inserm, and others
- Living mapping and living systematic review of COVID-19 studies. Chochrane, Inserm, and others
- Covid-19: Infrastructure for real-world monitoring of treatments and vaccines, EMA
- Putative primary endpoints for RCTs involving medicines used for the treatment of COVID-19, ICMRA
Ethical guidances
Ethical guidances
- Statement of the Swiss National Advisory Commission on Biomedical Ethics (NEK/CNE) on political decisions on measures to contain the SARS-CoV-2 pandemic. Nr. 38/2021. March 15, 2021. In German, in French, in Italian
- Regulatory – ethical considerations for ongoing trials during Pandemic, ECRIM
- Key criteria for the ethical acceptability of COVID-19 human challenge studies. WHO Working Group for Guidance on Human Challenge Studies in COVID-19, WHO, May 6, 2020
- Position of the European Network of Research Ethics Committees (EUREC) on the Responsibility of Research Ethics Committees during the COVID-19 Pandemic, April 27, 2020 during the COVID-19 Pandemic, April 27, 2020
- Statement of the Swiss National Advisory Commission on Biomedical Ethics (NEK/CNE) on contact tracing. Nr. 33/2020. April 6, 2020. In German, in French, in Italian
- Nuffield Council on Bioethics. Webinar 'Ethics in the research response to COVID-19' April 3, 2020
- Guidance for research ethics committees for rapid review of research during public health emergencies. WHO, May 28, 2020
- Nuffield Council on Bioethics. COVID-19 antibody testing and ‘immunity certification’, webinar, July 2, 2020; policy briefing, June 18, 2020